Lisa Egbuonu-Davis Buys Shares of Phreesia, Inc. (PHR)
Lisa Egbuonu-Davis acquired 19,290 shares of Phreesia, Inc. valued at nearly $185,000.
Key Points
- On June 24, 2026, Lisa Egbuonu-Davis bought 19,290 shares of Phreesia, Inc. at an average price of $9.59, totaling $184,991.
- Phreesia, Inc. has a market cap of $622.4 million, a P/E ratio of 62.94, and a 52-week range between $7.77 and $32.76.
- Analysts from firms like Truist Securities and Canaccord Genuity maintain diverse ratings, with price targets ranging from $9 to $16.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 24, 2026, Lisa Egbuonu-Davis purchased 19,290 shares of Phreesia, Inc. (NYSE: PHR) at an average price of $9.59 per share. This transaction was valued at approximately $184,991 and was not conducted under a pre-arranged trading plan.
Insider Buying and Selling at Phreesia, Inc.
Lisa Egbuonu-Davis was among several insiders who bought shares of Phreesia, Inc. on June 24, 2026. Other insiders, including Lainie Goldstein, Mark Douglas Smith, Ramin Sayar, and Gillian Munson, each acquired 19,290 shares at the same price of $9.59. On June 25, 2026, Lisa Egbuonu-Davis sold 2,546 shares at $9.53 per share in a planned transaction.
Other Institutional Activity in Phreesia, Inc.
Several institutional investors have shown interest in Phreesia, Inc. recently. Pale Fire Capital SE opened a new position with 8,649,329 shares valued at $72.48 million. BlackRock, Inc. increased its holdings by 284,445 shares, reaching a total of 5,920,469 shares worth about $49.61 million, marking a 5.0% increase. Vanguard Portfolio Management LLC also initiated a new position with 3,335,121 shares valued at $27.95 million. AQR Capital Management LLC significantly boosted its stake by 1,415,465 shares, a 323.8% increase, totaling 1,852,559 shares valued at $15.52 million.
Phreesia, Inc. Stock Down 17.1%
As of Saturday, shares of Phreesia, Inc. (NYSE: PHR) traded near $9.13. The company has a market capitalization of approximately $622.4 million. It features a P/E ratio of 62.94 and a forward P/E of 6.27. With a beta of 0.884, the stock has experienced a 52-week low of $7.77 and a high of $32.76. The 50-day moving average stands at $9.38, while the 200-day moving average is $15.21. Phreesia's current ratio is 1.757, and its quick ratio is 1.433, with a debt-to-equity ratio of 25.775.
$PHR stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Phreesia, Inc. reported revenue of $495.6 million, reflecting a growth of 12.9%. The company achieved an EPS of $0.16, with a net margin of 1.85% and a return on equity of 2.86%. The next earnings report is scheduled for September 3, 2026.
Analysts Set New Price Targets
On May 29, 2026, Truist Securities maintained its hold rating on Phreesia, Inc. with a $12.00 price target. Citigroup also maintained a hold rating with the same target on May 28, 2026. Canaccord Genuity, on the same day, maintained a buy rating and set a target price of $16.00. DA Davidson echoed this sentiment with a buy rating and a $14.00 target. The consensus among 17 analysts suggests a buy rating, with a mean target price of $13.94.
About Phreesia, Inc.
Phreesia, Inc. provides a cloud-based software and payment platform for the healthcare sector in the U.S. and Canada. Its services include appointment optimization, patient communications, and integrated payment solutions. The company also offers digital tools for patient engagement and data capture. Headquartered in Wilmington, Delaware, Phreesia was founded in 2005 and is led by CEO Evan Roberts, employing around 1,789 people.
Bottom Line
Lisa Egbuonu-Davis's recent purchase of Phreesia shares highlights insider confidence in the company. Phreesia's stock has been experiencing fluctuations, with a broad range of analyst opinions and price targets. Investors often track insider transactions like this one to gauge sentiment, but it's important to remember that these filings reflect past actions and may not indicate current positions.
Get Phreesia, Inc. alerts
New 13F filings, insider trades, and analyst moves on $PHR, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.